CN103688931A - Bactericidal composition containing trifloxystrobin and antibiotic compounds - Google Patents
Bactericidal composition containing trifloxystrobin and antibiotic compounds Download PDFInfo
- Publication number
- CN103688931A CN103688931A CN201310637469.1A CN201310637469A CN103688931A CN 103688931 A CN103688931 A CN 103688931A CN 201310637469 A CN201310637469 A CN 201310637469A CN 103688931 A CN103688931 A CN 103688931A
- Authority
- CN
- China
- Prior art keywords
- bacterium ester
- oxime bacterium
- bactericidal composition
- jinggangmeisu
- zhongshengmycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a bactericidal composition containing trifloxystrobin and antibiotic compounds. The bactericidal composition comprises active components A and B, wherein the active component A is selected from trifloxystrobin; the active component B is any one selected from the following bactericides: validamycin, Zhongshengmycin, kasugamycin and polyoxin; and the weight ratio of the two active components A and B ranges from 64:1 to 1:64. The composition disclosed by the invention can be used for preventing and controlling various crop diseases and expanding the bacteriocidal spectrum and is remarkable in synergistic effect and higher in activity for diseases such as rice blast, sheath blight, glume blight, seedling blight, powdery mildew, leaf spot disease, downy mildew, blight, gray mold, leaf mold and the like; and in addition, the dosage of a pesticide is reduced, the quantity of the residual pesticide on crops is reduced, and environmental pollution is reduced.
Description
The application is for dividing an application, original application is the patent application " a kind of bactericidal composition containing oxime bacterium ester and antibiotic compound " of Shanxi Thompson Biological Technology Co., Ltd., the application number of original application is ︰ 201110080240.3, and original application day is 2011.3.31.
Technical field
The invention belongs to technical field of pesticide, relate to a kind of bactericidal composition containing oxime bacterium ester and antibiotic compound.
Background technology
Oxime bacterium ester (trifloxystrobin), molecular formula: C
20h
19f
3n
2o
4, chemical name: methyl (E)-methoxyl group imido grpup-{ (E)-α-[1-(α, the fluoro-m-tolyl of α-tri-)-ethyleneimino oxygen base]-o-tolyl } ethyl acetate.Oxime bacterium ester class wide-spectrum bactericide is the new fungicides of a class of successfully developing as bactericide lead compound from natural products Strobilurins.Characteristics such as thering is efficient, wide spectrum, protection, treat, root out, infiltration, systemic activity, resistance of rainwater washing against, lasting period are long.To Isosorbide-5-Nitrae-demethylation enzyme inhibitor, benzamides, it is effective that dicarboxyl amine and benzimidazole produce the bacterial strain of resistance, with at present existing bactericide without cross resistance.Nearly all Mycophytes (Ascomycetes, Basidiomycetes, Oomycete and Fungi Imperfecti) disease is all had to good activity as powdery mildew, rust, Ying's rot, net blotch, downy mildew, rice blast etc.To crop safety, because it is at soil, capable of being fast degraded in water, therefore environmentally safe.
In the real process of agricultural production, oxime bacterium ester single dose is used for a long time, and the problem easily producing is the drug-fast generation of germ.And that different cultivars composition carries out is composite, be to prevent and treat the very common method of resistance germ.Heterogeneity is carried out composite, according to practical application effect, judge certain composite be synergy, add and or antagonism.In most cases, the composite effect of agricultural chemicals is all additive effect, really has the seldom composite of synergistic effect, especially synergistic effect very obviously, synergy ratio very high composite just still less.Through inventor's research, after discovery is composite by oxime bacterium ester and jinggangmeisu, Zhongshengmycin, kasugarnycin, polyoxin, can produce good synergistic effect, and not yet open at home and abroad about the composite relevant report of oxime bacterium ester and jinggangmeisu, Zhongshengmycin, kasugarnycin, polyoxin.
Summary of the invention
A kind of bactericidal composition containing oxime bacterium ester and antibiotic compound, comprise effective active component, auxiliary agent and filler, it is characterized in that: A, B ratio of weight and number are 64 ︰ 1～1 ︰ 64, active components A is selected from oxime bacterium ester, and active component B is selected from a kind of in antibiotic compound jinggangmeisu, Zhongshengmycin, kasugarnycin, polyoxin.
Described a kind of bactericidal composition containing oxime bacterium ester and antibiotic compound, is characterized in that: the ratio of weight and number of A, two kinds of active components of B is 16 ︰ 1～1 ︰ 16.
The described bactericidal composition that contains oxime bacterium ester, is characterized in that: the ratio of weight and number of oxime bacterium ester and jinggangmeisu is 8 ︰ 1～1 ︰ 8.
The described bactericidal composition that contains oxime bacterium ester, is characterized in that: the ratio of weight and number of oxime bacterium ester and Zhongshengmycin is 8 ︰ 1～1 ︰ 8.
The described bactericidal composition that contains oxime bacterium ester, is characterized in that: the ratio of weight and number of oxime bacterium ester and kasugarnycin is 8 ︰ 1～1 ︰ 8.
The described bactericidal composition that contains oxime bacterium ester, is characterized in that: the ratio of weight and number of oxime bacterium ester and polyoxin is 8 ︰ 1～1 ︰ 8.
Conventionally in composition, active weight percentage is gross weight 1～90%, is preferably 5%～60%.According to different preparation types, active component content scope is different.Conventionally, liquid preparation contains 1～60% active substance by weight, is preferably 5～50%; Solid pharmaceutical preparation contains 1～90% active substance by weight, is preferably 5～80%.
In bactericidal composition of the present invention, at least contain a kind of surfactant, the dispersion of active component in water while being beneficial to use.Surface-active contents is 5～30% of total formulation weight amount, and surplus is solid or liquid diluent.
The selected surfactant of bactericidal composition of the present invention is known in those skilled in the art: can be selected from one or more in dispersant, wetting agent, binding agent or defoamer.According to different dosage form, in preparation, can also contain disintegrant known in those skilled in the art, antifreeze etc.
Described dispersant is selected from alkylnaphthalene sulfonate, two (alkyl) naphthalenesulfonate formaldehyde condensation compound, naphthalene sulfonic acid-formaldehyde condensation product, aryl phenol polyoxyethylene succinate sulfonate, octylphenol polyethylene oxyethylene group ether sulfate, polycarboxylate, lignosulfonates, the phonetic formaldehyde condensation products sulphate of alkylphenol-polyethenoxy, alkyl benzene sulfonate calcium salt, naphthalene sulfonic acid-formaldehyde condensation product sodium salt, alkylphenol-polyethenoxy is phonetic, aliphatic amine polyoxyethylene is phonetic, polyoxyethylene carboxylate, one or more during ester polyoxyethylene is phonetic.
Described wetting agent is selected from: one or more in lauryl sodium sulfate, neopelex, Nekal BX, wetting and penetrating agent F, spaonin powder, silkworm excrement, soapberry powder.
Described disintegrant is selected from: one or more in bentonite, urea, ammonium sulfate, aluminium chloride.
Described binding agent is selected from: one or more in gum Arabic, xanthans, sodium phosphate trimer, phenolic resins, sodium alginate, white dextrin, methylcellulose, PAA, polyvinylpyrrolidone, crospolyvinylpyrrolidone, polyethylene glycol, polyvinyl alcohol.
Described antifreeze is selected from: one or more in ethylene glycol, propane diols, glycerine, polyethylene glycol.
Described defoamer is selected from: silicone, C
8～10aliphatic alcohols, C
10～20one or more in saturated fat acids (as capric acid) and acid amides, silicone oil, silicone compound.
Described stabilizing agent is selected from one or more in sodium sorbate, butyl glycidyl ether, phenyl glycidyl ether, cresyl glycidyl ether, polyethylene glycol diglycidyl ether;
Described filler is selected from: one or more in kaolin, diatomite, bentonite, attapulgite, white carbon, starch, precipitated calcium carbonate.
Composition of the present invention can be by user before use through dilution or directly use.Its preparation can be prepared by common processing method, after being about to active substance and mixing with liquid flux or solid carrier, then adds surfactant as one or more in dispersant, stabilizing agent, wetting agent, adhesive, defoamer etc.
Bactericidal composition of the present invention, can be processed into acceptable formulation on any agricultural chemicals on demand, and wherein preferred dosage form has: wetting powder, water dispersible granules, suspending agent etc.
When making wetting powder, composition comprises following constituent content: oxime bacterium ester 1～64%, active component B1～64%, dispersant 5～10%, wetting agent 2～10%, filler add to 100%.
Active component oxime bacterium ester, active component B, dispersant, wetting agent, filler are mixed, in mixed cylinder, mix, after airslide disintegrating mill is pulverized, mix again, can be made into wetting powder product of the present invention.
Wetting powder the key technical indexes of the present invention:
When making water dispersible granules, composition comprises following constituent content: active component oxime bacterium ester 1～64%, active component B1～64%, dispersant 3～12%, wetting agent 1～8%, disintegrant 1～10%, binding agent 1～8%, filler add to 100%.
Active component oxime bacterium ester, active component B, dispersant, wetting agent, disintegrant, filler etc. are obtained to the particle diameter needing through air-flow crushing together, then add other auxiliary agents such as binding agent, obtain the materials of granulating.By item quantitatively send in fluidized bed granulation dryer through granulation and dry after, make water dispersible granules product of the present invention.
Water dispersible granules the key technical indexes of the present invention:
When making suspending agent, composition comprises following constituent content: active component oxime bacterium ester 1～50%, active component B1～32%, dispersant 2～10%, wetting agent 2～10%, defoamer 0.1～1%, binding agent 0.1～2%, antifreeze 0.1～8%, deionized water add to 100%.
Dispersant, wetting agent, defoamer, thickener, antifreeze in above-mentioned formulation material are mixed through high speed shear, add active component oxime bacterium ester, active component B, in ball mill, ball milling is 2～3 hours, makes diameter of particle all below 5 μ m, makes suspending agent product of the present invention.
Suspending agent the key technical indexes of the present invention:
The invention has the advantages that: after (1) oxime bacterium ester and antibiotic compound are composite, have and obviously continue synergistic effect; (2) expanded fungicidal spectrum, the diseases such as rice blast, banded sclerotial blight, glume blight, damping off, powdery mildew, leaf spot, downy mildew, fusarium wilt, gray mold, leaf mold have all been had to greater activity; (3) the present invention not with an organic solvent, is difficult for producing poisoning, is convenient to transportation and storage; (4) reduce the dosage of agricultural chemicals, reduced the residual quantity of agricultural chemicals on crop, alleviated environmental pollution.
Embodiment
The embodiment of the present invention is the method that adopts Toxicity Determination and field trial to combine.The embodiment of the present invention is the method that adopts Toxicity Determination and field trial to combine.First by Toxicity Determination, the synergy ratio (SR) after clear and definite two kinds of medicaments are composite by a certain percentage, SR < 0.5 is antagonism, 0.5≤SR≤1.5 are summation action, SR > 1.5 is synergistic effect, on this basis, then carries out field trial.
Oxime bacterium ester and active component B(B are selected from a kind of in jinggangmeisu, Zhongshengmycin, kasugarnycin, polyoxin) composite to target fungus Toxicity Determination
After the effective inhibition concentration scope of each medicament is determined in prerun, each medicament is established respectively 5 dosage by active constituent content and is processed, and establishes clear water contrast.With reference to < < farm-chemical indoor determination test rule bactericide > >, carry out, adopt mycelial growth rate method to measure the virulence of medicament to target fungus.After 72h, by right-angled intersection method, measure colony diameter, calculate and respectively process net growth, mycelial growth inhibition rate.
Net growth (mm)=measurement colony diameter-5
Mycelial growth inhibition rate is converted into probit value (y), and liquor strength (μ g/mL) converts logarithm value to (x), with method of least squares, tries to achieve virulence regression equation (y=a+bx), and calculates thus the EC of every kind of medicament
50value.According to Wadley method, calculate the different proportioning synergy ratio (SR) of two medicaments, SR < 0.5 is antagonism simultaneously, and 0.5≤SR≤1.5 are summation action, and SR > 1.5 is synergistic effect.Computing formula is as follows:
Wherein: a, b are respectively active component oxime bacterium ester and active component B(jinggangmeisu, Zhongshengmycin, kasugarnycin, polyoxin) shared ratio in combination;
A is oxime bacterium ester;
B is a kind of in jinggangmeisu, Zhongshengmycin, kasugarnycin, polyoxin.
Implementation of an application example one
Oxime bacterium ester and composite jinggangmycin are to the sick Toxicity Determination of rice sheath blight disease
Test medicine provides by Shanxi Thompson Biological Technology Co., Ltd..
Experimental scheme: effective inhibition concentration scope of determining oxime bacterium ester, the former medicine of jinggangmeisu and the two different proportioning mixture through preliminary experiment.
Toxicity test result
Table 1 oxime bacterium ester, jinggangmeisu and the composite toxicity test analysis of results table to rice sheath blight disease thereof
As shown in Table 1, oxime bacterium ester, the EC of jinggangmeisu to rice sheath blight disease
50be respectively 0.65mg/L and 0.78mg/L.Oxime bacterium ester and jinggangmeisu proportioning are when 64:1 to 1:64, synergy ratio SR is all greater than 1.5, illustrate that oxime bacterium ester and jinggangmeisu are mixed and all show synergistic effect in 64 ︰ 1 to 1 ︰ 64 scopes, especially, when the two proportioning is during at 8:1 to 1:8, synergistic effect is the most obvious.
Implementation of an application example two
Oxime bacterium ester and Zhongshengmycin are composite to sigatoka Toxicity Determination
Test medicine provides by Shanxi Thompson Biological Technology Co., Ltd..
Experimental scheme: effective inhibition concentration scope of determining oxime bacterium ester, the former medicine of Zhongshengmycin and the two different proportioning mixture through preliminary experiment.
Toxicity test result
Table 2 oxime bacterium ester, Zhongshengmycin and the composite toxicity test analysis of results table to sigatoka thereof
As shown in Table 2, oxime bacterium ester, the EC of Zhongshengmycin to sigatoka
50be respectively 1.12mg/L and 0.96mg/L.Oxime bacterium ester and Zhongshengmycin proportioning are when 64:1 to 1:64, synergy ratio SR is all greater than 1.5, illustrate that oxime bacterium ester and Zhongshengmycin are mixed and all show synergistic effect in 64 ︰ 1 to 1 ︰ 64 scopes, especially, when the two proportioning is during at 8:1 to 1:8, synergistic effect is more obviously outstanding.
Implementation of an application example three:
Oxime bacterium ester and kasugarnycin are composite to wheat powdery mildew Toxicity Determination.
Test medicine provides by Shanxi Thompson Biological Technology Co., Ltd..
Experimental scheme: effective inhibition concentration scope of determining oxime bacterium ester, the former medicine of kasugarnycin and the two different proportioning mixture through preliminary experiment.
Toxicity test result
Table 3 oxime bacterium ester, kasugarnycin and the composite toxicity test analysis of results table to wheat powdery mildew thereof
As shown in Table 3, oxime bacterium ester, the EC of kasugarnycin to wheat powdery mildew
50be respectively 0.81mg/L and 0.73mg/L.Oxime bacterium ester and kasugarnycin are than when the 64:1 to 1:64, synergy ratio SR is all greater than 1.5, illustrate that oxime bacterium ester and kasugarnycin are mixed and all show synergistic effect in 64 ︰ 1 to 1 ︰ 64 scopes, especially, when the two proportioning is during at 8:1 to 1:8, synergistic effect is more outstanding.
Implementation of an application example four
Oxime bacterium ester and polyoxin are composite to cladosporium leaf and fruit mould of tomato Toxicity Determination
Test medicine provides by Shanxi Thompson Biological Technology Co., Ltd..
Experimental scheme: effective inhibition concentration scope of determining oxime bacterium ester, the former medicine of polyoxin and the two different proportioning mixture through preliminary experiment.
Toxicity test result
Table 2 oxime bacterium ester, polyoxin and the composite toxicity test analysis of results table to cladosporium leaf and fruit mould of tomato thereof
As shown in Table 2, oxime bacterium ester, the EC of polyoxin to cladosporium leaf and fruit mould of tomato
50be respectively 0.70mg/L and 0.58mg/L.Oxime bacterium ester and polyoxin proportioning are when 64:1 to 1:64, synergy ratio SR is all greater than 1.5, illustrate that oxime bacterium ester and polyoxin are mixed and all show synergistic effect in 64 ︰ 1 to 1 ︰ 64 scopes, especially, when the two proportioning is during at 8:1 to 1:8, synergistic effect is more obviously outstanding.
Application Example four the implementation of Formulation Example
Below in conjunction with embodiment, to further instruction of the present invention, the portion rate in embodiment is all weight percentage, but the present invention is not limited thereto.
Embodiment 1 20% oxime bacterium ester jinggangmeisu wetting powder
Oxime bacterium ester 10%, jinggangmeisu 10%, polycarboxylate 3%, soapberry powder 4%, diatomite add to 100%, and mixture carries out air-flow crushing, make 20% oxime bacterium ester jinggangmeisu wetting powder.
Embodiment 2 35% oxime bacterium ester jinggangmeisu wetting powders
Oxime bacterium ester 20%, jinggangmeisu 15%, lignosulfonates 3%, wetting and penetrating agent F3%, attapulgite add to 100%, and mixture carries out air-flow crushing, make 35% oxime bacterium ester jinggangmeisu wetting powder.
Embodiment 3 65% oxime bacterium ester jinggangmeisu wetting powders
Oxime bacterium ester 60%, jinggangmeisu 5%, aryl phenol polyoxyethylene succinate sulfonate 4%, spaonin powder 3%, white carbon add to 100%, and mixture carries out air-flow crushing, make 65% oxime bacterium ester jinggangmeisu wetting powder.
Embodiment 4 18% oxime bacterium ester jinggangmeisu water dispersible granules
Oxime bacterium ester 2%, jinggangmeisu 16%, lauryl sodium sulfate 5%, polyoxyethylene carboxylate 3%, aluminium chloride 1%, bentonite 10%, kaolin add to 100%, mix and make 18% oxime bacterium ester jinggangmeisu water dispersible granules.
Embodiment 5 28% oxime bacterium ester jinggangmeisu water dispersible granules
Oxime bacterium ester 4%, jinggangmeisu 24%, soapberry powder 3%, naphthalene sulfonic acid-formaldehyde condensation product sodium salt 4%, bentonite 10%, diatomite add to 100%, mix and make 28% oxime bacterium ester jinggangmeisu water dispersible granules.
Embodiment 6 45% oxime bacterium ester jinggangmeisu water dispersible granules
Oxime bacterium ester 40%, jinggangmeisu 5%, spaonin powder 5%, alkyl benzene sulfonate calcium salt 4%, urea 1%, kaolin add to 100%, mix and make 45% oxime bacterium ester jinggangmeisu water dispersible granules.
Embodiment 7 15% oxime bacterium ester jinggangmeisu suspending agents
Oxime bacterium ester 5%, jinggangmeisu 10%, polycarboxylate 5%, neopelex 5%, C
8～10aliphatic alcohols 0.5%, methylcellulose 1%, propane diols 1.6%, deionized water add to 100%, mix and make 15% oxime bacterium ester jinggangmeisu suspending agent.
Embodiment 8 20% oxime bacterium ester jinggangmeisu suspending agents
Oxime bacterium ester 4%, jinggangmeisu 16%, naphthalene sulfonic acid-formaldehyde condensation product 4%, silkworm excrement 3%, silicone compound 0.2%, polyvinylpyrrolidone 0.8%, polyethylene glycol 1.5%, deionized water add to 100%, mix and make 20% oxime bacterium ester jinggangmeisu suspending agent.
Embodiment 9 48% oxime bacterium ester jinggangmeisu suspending agents
Oxime bacterium ester 40%, jinggangmeisu 8%, the phonetic formaldehyde condensation products sulphate 3% of alkylphenol-polyethenoxy, neopelex 4%, C
10～20saturated fat acids 0.5%, sodium phosphate trimer 1%, glycerine 1.5%, deionized water add to 100%, mix and make 48% oxime bacterium ester jinggangmeisu suspending agent.
Embodiment 10 24% oxime bacterium ester Zhongshengmycin wetting powders
Oxime bacterium ester 8%, Zhongshengmycin 16%, naphthalene sulfonic acid-formaldehyde condensation product sodium salt 3%, silkworm excrement 3%, diatomite add to 100%, and mixture carries out air-flow crushing, make 24% oxime bacterium ester Zhongshengmycin wetting powder.
Embodiment 11 45% oxime bacterium ester Zhongshengmycin wetting powders
Oxime bacterium ester 30%, Zhongshengmycin 15%, polycarboxylate 3%, Nekal BX 4%, bentonite add to 100%, and mixture carries out air-flow crushing, make 45% oxime bacterium ester Zhongshengmycin wetting powder.
Embodiment 12 60% oxime bacterium ester Zhongshengmycin wetting powders
Oxime bacterium ester 40%, Zhongshengmycin 20%, lignosulfonates 3%, soapberry powder 4%, kaolin add to 100%, and mixture carries out air-flow crushing, make 60% oxime bacterium ester Zhongshengmycin wetting powder.
Embodiment 13 30% oxime bacterium ester Zhongshengmycin water dispersible granules
Oxime bacterium ester 10%, Zhongshengmycin 20%, the phonetic formaldehyde condensation products sulphate 3% of alkylphenol-polyethenoxy, spaonin powder 2%, urea 1%, attapulgite add to 100%, mix and make 30% oxime bacterium ester Zhongshengmycin water dispersible granules.
Embodiment 14 50% oxime bacterium ester Zhongshengmycin water dispersible granules
Oxime bacterium ester 40%, Zhongshengmycin 10%, lignosulfonates 4%, soapberry powder 4%, ammonium sulfate 0.8%, bentonite add to 100%, mix and make 50% oxime bacterium ester Zhongshengmycin water dispersible granules.
Embodiment 15 40% oxime bacterium ester Zhongshengmycin water dispersible granules
Oxime bacterium ester 15%, Zhongshengmycin 25%, naphthalene sulfonic acid-formaldehyde condensation product sodium salt 3%, wetting and penetrating agent F4%, urea 5%, kaolin add to 100%, mix and make 40% oxime bacterium ester Zhongshengmycin water dispersible granules.
Embodiment 16 12% oxime bacterium ester Zhongshengmycin suspending agents
Oxime bacterium ester 4%, Zhongshengmycin 8%, polyoxyethylene carboxylate 4%, soapberry powder 3%, silicone oil 0.3%, xanthans 1%, glycerine 1.3%, deionized water add to 100%, mix and make 12% oxime bacterium ester Zhongshengmycin suspending agent.
Embodiment 17 25% oxime bacterium ester Zhongshengmycin suspending agents
Oxime bacterium ester 20%, Zhongshengmycin 5%, alkyl benzene sulfonate calcium salt 3%, lauryl sodium sulfate 4%, silicone compound 0.5%, sodium phosphate trimer 1.5%, ethylene glycol 1.5%, deionized water add to 100%, mix and make 25% oxime bacterium ester Zhongshengmycin suspending agent.
Embodiment 18 40% oxime bacterium ester Zhongshengmycin suspending agents
Oxime bacterium ester 10%, Zhongshengmycin 30%, polycarboxylate 3%, wetting and penetrating agent F5%, silicone oil 0.2%, polyvinylpyrrolidone 1%, polyethylene glycol 1.6%, deionized water add to 100%, mix and make 40% oxime bacterium ester Zhongshengmycin suspending agent.
Embodiment 19 18% oxime bacterium ester kasugarnycin wetting powders
Oxime bacterium ester 6%, kasugarnycin 12%, the phonetic formaldehyde condensation products sulphate 3% of alkylphenol-polyethenoxy, silkworm excrement 3%, bentonite add to 100%, and mixture carries out air-flow crushing, make 18% oxime bacterium ester kasugarnycin wetting powder.
Embodiment 20 50% oxime bacterium ester kasugarnycin wetting powders
Oxime bacterium ester 40%, kasugarnycin 10%, lignosulfonates 3%, spaonin powder 5%, diatomite add to 100%, and mixture carries out air-flow crushing, make 50% oxime bacterium ester kasugarnycin wetting powder.
Embodiment 21 65% oxime bacterium ester kasugarnycin wetting powders
Oxime bacterium ester 64%, kasugarnycin 1%, polyoxyethylene carboxylate 3%, wetting and penetrating agent F4%, kaolin add to 100%, and mixture carries out air-flow crushing, make 65% oxime bacterium ester kasugarnycin wetting powder.
Embodiment 22 9% oxime bacterium ester kasugamycin water-dispersion granules
Oxime bacterium ester 8%, kasugarnycin 1%, aryl phenol polyoxyethylene succinate sulfonate 3%, Nekal BX 4%, sodium sulphate 1%, bentonite add to 100%, mix and make 9% oxime bacterium ester kasugamycin water-dispersion granule.
Embodiment 23 25% oxime bacterium ester kasugamycin water-dispersion granules
Oxime bacterium ester 20%, kasugarnycin 5%, aliphatic amine polyoxyethylene are phonetic 3%, wetting and penetrating agent F3%, aluminium chloride 0.8%, attapulgite add to 100%, mix and make 25% oxime bacterium ester kasugamycin water-dispersion granule.
Embodiment 24 45% oxime bacterium ester kasugamycin water-dispersion granules
Oxime bacterium ester 40%, kasugarnycin 5%, naphthalene sulfonic acid-formaldehyde condensation product 4%, soapberry powder 5%, urea 1.2%, bentonite add to 100%, mix and make 45% oxime bacterium ester kasugamycin water-dispersion granule.
Embodiment 25 27% oxime bacterium ester kasugarnycin suspending agents
Oxime bacterium ester 18%, kasugarnycin 9%, naphthalene sulfonic acid-formaldehyde condensation product sodium salt 4%, neopelex 3%, C
8～10aliphatic alcohols 0.7%, gum Arabic 0.8%, glycerine 1.4%, deionized water add to 100%, mix and make 27% oxime bacterium ester kasugarnycin suspending agent.
Embodiment 26 33% oxime bacterium ester kasugarnycin suspending agents
Oxime bacterium ester 32%, kasugarnycin 1%, alkyl benzene sulfonate calcium salt 3%, wetting and penetrating agent F4%, silicone oil 0.2%, polyvinylpyrrolidone 1%, polyethylene glycol 1.7%, deionized water add to 100%, mix and make 33% oxime bacterium ester kasugarnycin suspending agent.
Embodiment 27 40% oxime bacterium ester kasugarnycin suspending agents
Oxime bacterium ester 32%, kasugarnycin 8%, polyoxyethylene carboxylate 5%, soapberry powder 2%, silicone compound 0.5%, sodium phosphate trimer 0.6%, propane diols 1.2%, deionized water add to 100%, mix and make 40% oxime bacterium ester kasugarnycin suspending agent.
Embodiment 28 20% oxime bacterium ester polyoxin wetting powders
Oxime bacterium ester 12%, polyoxin 8%, polycarboxylate 3%, soapberry powder 4%, diatomite add to 100%, and mixture carries out air-flow crushing, make 20% oxime bacterium ester polyoxin wetting powder.
Embodiment 29 35% oxime bacterium ester polyoxin wetting powders
Oxime bacterium ester 25%, polyoxin 10%, lignosulfonates 3%, wetting and penetrating agent F3%, attapulgite add to 100%, and mixture carries out air-flow crushing, make 35% oxime bacterium ester polyoxin wetting powder.
Embodiment 30 65% oxime bacterium ester polyoxin wetting powders
Oxime bacterium ester 60%, polyoxin 5%, aryl phenol polyoxyethylene succinate sulfonate 4%, spaonin powder 3%, white carbon add to 100%, and mixture carries out air-flow crushing, make 65% oxime bacterium ester polyoxin wetting powder.
Embodiment 31 18% oxime bacterium ester polyoxin water dispersible granules
Oxime bacterium ester 3%, polyoxin 15%, lauryl sodium sulfate 5%, polyoxyethylene carboxylate 3%, aluminium chloride 1%, bentonite 10%, kaolin add to 100%, mix and make 18% oxime bacterium ester polyoxin water dispersible granules.
Embodiment 32 28% oxime bacterium ester polyoxin water dispersible granules
Oxime bacterium ester 18%, polyoxin 10%, soapberry powder 3%, naphthalene sulfonic acid-formaldehyde condensation product sodium salt 4%, bentonite 10%, diatomite add to 100%, mix and make 28% oxime bacterium ester polyoxin water dispersible granules.
Embodiment 33 45% oxime bacterium ester polyoxin water dispersible granules
Oxime bacterium ester 42%, polyoxin 3%, spaonin powder 5%, alkyl benzene sulfonate calcium salt 4%, urea 1%, kaolin add to 100%, mix and make 45% oxime bacterium ester polyoxin water dispersible granules.
Embodiment 34 15% oxime bacterium ester polyoxin suspending agents
Oxime bacterium ester 5%, polyoxin 10%, polycarboxylate 5%, neopelex 5%, C
8～10aliphatic alcohols 0.5%, methylcellulose 1%, propane diols 1.6%, deionized water add to 100%, mix and make 15% oxime bacterium ester polyoxin suspending agent.
Embodiment 35 20% oxime bacterium ester polyoxin suspending agents
Oxime bacterium ester 5%, polyoxin 15%, naphthalene sulfonic acid-formaldehyde condensation product 4%, silkworm excrement 3%, silicone compound 0.2%, polyvinylpyrrolidone 0.8%, polyethylene glycol 1.5%, deionized water add to 100%, mix and make 20% oxime bacterium ester polyoxin suspending agent.
Embodiment 36 48% oxime bacterium ester polyoxin suspending agents
Oxime bacterium ester 42%, polyoxin 6%, the phonetic formaldehyde condensation products sulphate 3% of alkylphenol-polyethenoxy, neopelex 4%, C
10～20saturated fat acids 0.5%, sodium phosphate trimer 1%, glycerine 1.5%, deionized water add to 100%, mix and make 48% oxime bacterium ester polyoxin suspending agent.
In above-described embodiment, the ratio of A, two kinds of active components of B can be adjusted within the scope of the synergy of 64 ︰ 1～1 ︰ 64, thereby forms new embodiment.
Application Example five oxime bacterium esters and jinggangmeisu and the composite rice sheath blight disease test of pesticide effectiveness of preventing and treating thereof
This experimental establishment is in the suburb of Liuzhou City, Guangxi province, and test medicine is researched and developed, provided by Shanxi Thompson Biological Technology Co., Ltd., contrast medicament 25% oxime bacterium ester suspending agent (commercial), 10% jinggangmeisu aqua (commercial).
Investigation rice sheath blight disease disease index before medicine, in their early stage dispenser, dispenser for the second time after 10 days, dispenser is 2 times altogether, within after dispenser 7 days, 21 days for the second time, investigates disease indexs and calculates preventive effect.Experimental result is as follows:
Table 4 oxime bacterium ester, jinggangmeisu and the composite rice sheath blight disease test of pesticide effectiveness of preventing and treating thereof
As can be seen from Table 4, after oxime bacterium ester and composite jinggangmycin, can effectively prevent and treat rice sheath blight disease, control efficiency is all better than the preventive effect of single dose.In test scope of medication, target crop is had no adverse effects, and rice blast disease is had to good preventive effect, preventive effect reaches more than 90%.
Application Example six oxime bacterium esters and Zhongshengmycin and the composite sigatoka test of pesticide effectiveness of preventing and treating thereof
This experimental establishment is in Kaiyuan City county, Yunnan Province, and test medicine is researched and developed, provided by Shanxi Thompson Biological Technology Co., Ltd., contrast medicament 25% oxime bacterium ester suspending agent (commercial), 3% Zhongshengmycin wetting powder (commercial).
The investigation sigatoka state of an illness before medicine, in the dispenser for the first time of state of an illness initial stage, once, dispenser is 3 times altogether in dispenser in every 7 days.Within after dispenser 7 days, 21 days for the third time, investigate respectively disease index and calculate preventive effect.Experimental result is as follows:
Table 5 oxime bacterium ester, Zhongshengmycin and the composite sigatoka test of pesticide effectiveness of preventing and treating thereof
As can be seen from Table 5, after oxime bacterium ester and Zhongshengmycin are composite, can effectively prevent and treat sigatoka, control efficiency is all better than the preventive effect of single dose.In test scope of medication, target crop is had no adverse effects, and apple leaf spot is had to good preventive effect, preventive effect reaches more than 91%.
Application Example seven oxime bacterium esters and kasugarnycin and the composite control cucumber downy mildew test of pesticide effectiveness thereof
This experimental establishment is in Shun Qiang county, Hebei province, and test medicine is researched and developed, provided by Shanxi Thompson Biological Technology Co., Ltd., contrast medicament 25% oxime bacterium ester suspending agent (commercial), 2% kasugarnycin wetting powder (commercial).
Investigation cucumber downy mildew disease index before medicine, in their early stage dispenser, dispenser for the second time after 10 days, dispenser is 2 times altogether, within after dispenser 7 days, 21 days for the second time, investigates disease indexs and calculates preventive effect.Experimental result is as follows:
Table 6 oxime bacterium ester, kasugarnycin and the composite control cucumber downy mildew test of pesticide effectiveness thereof
As can be seen from Table 6, after oxime bacterium ester and kasugarnycin are composite, can effectively prevent and treat cucumber downy mildew, control efficiency is all better than the preventive effect of single dose.In test scope of medication, target crop is had no adverse effects.
Application Example eight oxime bacterium esters and polyoxin and the composite apple mildew test of pesticide effectiveness of preventing and treating thereof
This experimental establishment is in Liquan County, Shaanxi Province, and test medicine is researched and developed, provided by Shanxi Thompson Biological Technology Co., Ltd., contrast medicament 25% oxime bacterium ester suspending agent (commercial), 3% polyoxin wetting powder (commercial).
The investigation apple mildew state of an illness before medicine, in the dispenser for the first time of state of an illness initial stage, once, dispenser is 3 times altogether in dispenser in every 7 days.Within after dispenser 7 days, 21 days for the third time, investigate respectively disease index and calculate preventive effect.Experimental result is as follows:
Table 7 oxime bacterium ester, polyoxin and the composite apple mildew test of pesticide effectiveness of preventing and treating thereof
As can be seen from Table 7, after oxime bacterium ester and polyoxin are composite, can effectively prevent and treat apple mildew, control efficiency is all better than the preventive effect of single dose.In test scope of medication, target crop is had no adverse effects, and apple leaf spot is had to good preventive effect, preventive effect reaches more than 91%.
Claims (6)
1. the bactericidal composition containing oxime bacterium ester and antibiotic compound, comprise effective active component, auxiliary agent and filler, it is characterized in that: A, two kinds of active component ratios of weight and number of B are 64 ︰ 1～1 ︰ 64, and described A is selected from oxime bacterium ester, and B is selected from antibiotic compound jinggangmeisu.
2. the bactericidal composition containing oxime bacterium ester and antibiotic compound according to claim 1, is characterized in that: the ratio of weight and number of oxime bacterium ester and jinggangmeisu is 16 ︰ 1～1 ︰ 16.
3. the bactericidal composition containing oxime bacterium ester and antibiotic compound according to claim 2, is characterized in that: the ratio of weight and number of oxime bacterium ester and jinggangmeisu is 8 ︰ 1～1 ︰ 8.
4. the bactericidal composition containing oxime bacterium ester and antibiotic compound according to claim 1, is characterized in that: wherein effective active component content accounts for 1～80% of gross weight.
5. the bactericidal composition containing oxime bacterium ester and antibiotic compound according to claim 4, is characterized in that: wherein effective active component content accounts for 5～60% of gross weight.
6. the bactericidal composition containing oxime bacterium ester and antibiotic compound according to claim 1 is for preventing and treating the application of rice blast, banded sclerotial blight, glume blight, damping off, powdery mildew, leaf spot, downy mildew, fusarium wilt, gray mold, leaf mold.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310637469.1A CN103688931A (en) | 2011-03-31 | 2011-03-31 | Bactericidal composition containing trifloxystrobin and antibiotic compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310637469.1A CN103688931A (en) | 2011-03-31 | 2011-03-31 | Bactericidal composition containing trifloxystrobin and antibiotic compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110080240.3A Division CN102217618B (en) | 2011-03-31 | 2011-03-31 | Bactericidal composition containing trifloxystrobin and antibiotic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103688931A true CN103688931A (en) | 2014-04-02 |
Family
ID=50350724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310637469.1A Pending CN103688931A (en) | 2011-03-31 | 2011-03-31 | Bactericidal composition containing trifloxystrobin and antibiotic compounds |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103688931A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1561724A (en) * | 2004-03-18 | 2005-01-12 | 南京农业大学 | Biological-chemical synergistic sterilizer and its use |
| CN1957699A (en) * | 2006-11-24 | 2007-05-09 | 华南理工大学 | Micellar emulsion prepared by mixing Kresoxim and jinggangmycin and preparation method |
| JP2007246495A (en) * | 2006-03-20 | 2007-09-27 | Mitsui Chemicals Inc | Method for controlling disease and insect pest |
-
2011
- 2011-03-31 CN CN201310637469.1A patent/CN103688931A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1561724A (en) * | 2004-03-18 | 2005-01-12 | 南京农业大学 | Biological-chemical synergistic sterilizer and its use |
| JP2007246495A (en) * | 2006-03-20 | 2007-09-27 | Mitsui Chemicals Inc | Method for controlling disease and insect pest |
| CN1957699A (en) * | 2006-11-24 | 2007-05-09 | 华南理工大学 | Micellar emulsion prepared by mixing Kresoxim and jinggangmycin and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102017955B (en) | Bactericidal composite containing metconazole and methoxy acrylate compounds | |
| CN102224822B (en) | Microbicidal composition containing chloroisobromine cyanuric acid and antibiotics | |
| CN102057914B (en) | Bactericidal composition containing metconazole and antibiotic compound | |
| CN102302026A (en) | Bactericidal composition containing pyraclostrobin and antibiotic compounds | |
| CN102067851B (en) | Antibacterial composition containing polyoxin and methoxyacrylate compound | |
| CN102057908B (en) | Bactericidal composite containing dithianon and methoxy acrylic esters | |
| CN102204552A (en) | Antibacterial composition containing enestroburin and antibiotic compound | |
| CN102057913B (en) | Bactericidal composition containing triflumizole and triazole compound | |
| CN102057909B (en) | Bactericidal composition containing triflumizole and antibiotic compounds | |
| CN102217618B (en) | Bactericidal composition containing trifloxystrobin and antibiotic compounds | |
| CN102007934B (en) | Bactericidal composition containing phosethyl-Al and antibiotic compound | |
| CN102047893B (en) | Bactericidal composition containing captan and antibiotic compound | |
| CN102057927A (en) | Bactericidal composition containing captan and triazole compounds | |
| CN102007914A (en) | Triflumizole-containing synergistic sterilization composition | |
| CN103719086A (en) | Sterilization composite containing trifloxystrobin and antibiotics compound | |
| CN102037974B (en) | Sterilization composition containing triticonazole and methoxyl acrylate | |
| CN102090407B (en) | Bactericidal composition containing bitertanol and antibiotic type compound | |
| CN103688931A (en) | Bactericidal composition containing trifloxystrobin and antibiotic compounds | |
| CN102027935B (en) | Bactericidal composition containing dithianone and triazole compound | |
| CN102204544A (en) | Picoxystrobin-containing synergic bactericidal composition | |
| CN102057935B (en) | Bactericidal composition containing imidazole | |
| CN102067862A (en) | Ipconazole-containing bactericidal composition | |
| CN101999366A (en) | Bactericide composition containing ethirimol | |
| CN102150673B (en) | Captan-containing bactericidal composition | |
| CN103392719B (en) | Bactericidal composition containing iminazoles and methoxy acrylates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140402 |